LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRXBiotechnology
Healthcare
$40.06 -1.30%
-$0.39 today
- Market cap
- $1.30B
- Beta
- 0.71
- P/E (TTM)
- -21.4
- EPS (TTM)
- -$1.39
52W Low $13.36High $33.47
Volume 0.36M
Average 0.23M
Price history
LB Pharmaceuticals Inc Common Stock SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+151.63%
Period high
$49.48
Period low
$15.33
Latest
$40.06
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Oct 13, 2026 | Oct 13, 2026 | |
| 4 | Oct 13, 2026 | Oct 13, 2026 | |
| SC 13G/A | Oct 13, 2026 | Oct 13, 2026 | |
| EFFECT | Oct 5, 2026 | Oct 6, 2026 | |
| POS AM | Oct 1, 2026 | Oct 1, 2026 | |
| S-3ASR | Oct 1, 2026 | Oct 1, 2026 | |
| 3 | Sep 24, 2026 | Sep 24, 2026 | |
| 424B3 | Sep 15, 2026 | Sep 15, 2026 | |
| 8-K | Sep 15, 2026 | Sep 15, 2026 | |
| 3 | Sep 14, 2026 | Sep 14, 2026 | |
| 424B3 | Sep 3, 2026 | Sep 3, 2026 | |
| 8-K | Sep 3, 2026 | Sep 3, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 |
Competitors
Who does LB Pharmaceuticals Inc Common Stock compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about LBRX's filings, answered from its disclosures.
What is the latest LBRX filing?
The latest filing shown is 10-Q dated Nov 5, 2026.
How many recent filings does LBRX have?
Intrinsic Alpha currently shows 20 recent filings for LBRX.
Continue the stock analysis
Jump to another research area for this company.